Compound Detail
CHEMBL471
SOTALOL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL471 |
| Name | SOTALOL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | ZBMZVLHSJCTVON-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
7
Targets
18
Activities
4
Assay Types
11
PK Parameters
20
Publications
4
Known Names
9
Indications
Molecular Properties
272.4
MW (Da)
1.09
ALogP
4
HBA
3
HBD
78.4
PSA (Ų)
0.72
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1992 |
| Availability | Prescription |
| Chirality | Racemic |
Indications
Cardiovascular Diseases Arrhythmias, Cardiac Atrial Fibrillation Death, Sudden, Cardiac Heart Diseases Heart Failure Myocardial Infarction Tachycardia, Ventricular Ventricular Fibrillation
ATC Classification
C07AA07
sotalol
Level 1: CARDIOVASCULAR SYSTEM
Level 2: BETA BLOCKING AGENTS
Activity Summary
IC50 12 meas. best 6.36
Ki 3 meas. best 6.53
Kd 2 meas. best 6.8
EC50 1 meas.
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | Kd | 6.8 | 6.8 | 158.5 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | Ki | 6.53 | 6.53 | 298.3 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | IC50 | 6.36 | 6.36 | 433.9 | 1 |
| Beta-2 adrenergic receptor CHEMBL3373 | Kd | 6.24 | 6.24 | 580.0 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | Ki | 6.08 | 6.08 | 833.5 | 1 |
| T-cell line CHEMBL614685 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | IC50 | 5.84 | 5.2475 | 1443.4 | 4 |
| Beta-2 adrenergic receptor CHEMBL2289 | IC50 | 5.3 | 5.2933 | 5000.0 | 3 |
| Adrenergic receptor beta CHEMBL2094118 | IC50 | 5.14 | 5.14 | 7200.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 2.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 14.1 | mL.min-1.g-1 | Homo sapiens |
| F | 95.0 | % | Homo sapiens |
| Fu | 1.0 | - | Homo sapiens |
| Fu | 0.62 | - | Homo sapiens |
| Fu | 0.62 | - | Homo sapiens |
| MRT | 11.0 | hr | Homo sapiens |
| T1/2 | 6.3 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 467 |
| - | 10.5281/zenodo.13943903 | ADMET | 89 |
| 31158845 | 10.1038/s41586-019-1291-3 | ADMET | 68 |
| - | 10.6019/CHEMBL4295262 | Unchecked | 32 |
| 1956040 | 10.1021/jm00115a010 | Canis familiaris | 26 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 1542097 | 10.1021/jm00082a011 | Canis familiaris | 16 |
| 2308138 | 10.1021/jm00165a003 | Canis familiaris | 15 |
| 2319556 | 10.1021/jm00166a002 | Canis familiaris | 14 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 3681900 | 10.1021/jm00395a021 | Canis familiaris | 10 |
| 1347318 | 10.1021/jm00082a016 | Canis familiaris | 9 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 1976812 | 10.1021/jm00172a033 | Canis familiaris | 8 |
| 19309156 | 10.1021/jm801228h | Unchecked | 5 |
| 1976812 | 10.1021/jm00172a033 | NON-PROTEIN TARGET | 4 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 3572962 | 10.1021/jm00388a001 | Canis familiaris | 4 |
Data from ChEMBL 36 via Core Engine